Terebellum, the Ireland and UK-based subsidiary of AscellaHealth, has announced a contractual partnership with NeurosolvTherapeutics.
The move brings its full suite of capabilities to support the launch of Perineline, a new patented two-part therapy for spinal cord injuries developed by NeurosolvTherapeutics that has now attained EMA Orphan Designation and is expected to end patient outcomes from spinal cord injuries.
Terebellum’s services include strategic guidance in the pre-commercialisation stage, market access expertise, and supply chain logistics including distribution and fulfilment.
Craig Caceci, Executive Vice President and Managing Director, Terebellum, said: “Our dedicated team of highly experienced market access professionals look forward to working closely with NeursolvTherapeutics in a successful product launch that establishes optimal pricing and ensures seamless product access for patients with spinal cord injuries. This is an exciting time to be introducing a game-changing therapeutic treatment.”
At every step of the way, we know that we can rely upon Terebellum for key strategic insights throughout the implementation process
NeursolvTherapeutics selected Terebellum based upon its comprehensive suite of integrated solutions, including strategic insights for early-stage products, deep bench market access expertise throughout Europe and the United States, supply chain logistics and exclusive distribution and fulfilment services.
Aidan Lynch, Chairman and Chief Executive Officer, NeursolvTherapeutics, said: “We are excited to work with Terebellum to bring Perineline to market globally, to allow us to proliferate and enable ethically controlled patient access under spinal cord trauma consultants.”
Lynch continued: “Terebellum’s consultative business model and collaborative approach enables us to take advantage of their thorough expertise and knowledge which are critical to the launch planning and commercialisation of Perineline. At every step of the way, we know that we can rely upon Terebellum for key strategic insights throughout the implementation process.”
